formed by the aggregation of blood cells, platelets and clotting and growth factors. During the nor mal healing process, fibrinolytic activity prevents the formation of fibrin deposits and abnormal tissue attachments. However, if fibrinolysis is sup pressed (e.g., by tissue ischemia and hypoxia), then fibrin deposits may persist and develop into adhesions. The physical trauma of surgery and the resulting tissue ischemia is a key factor in the formation of adhesions. Others include residual blood, post operative infection, inflammation and foreign bodies (e.g., sutures) [8, 9] . Adhesions are often described as filmy or dense. Filmy adhe sions tend to be weak and stringy, with few blood vessels, and are generally easy to cut or remove. Dense adhesions tightly connect tissues, which makes this type of adhesion difficult to remove. They may contain blood vessels and are more likely to recur after removal. However, adhesions can be categorized or scored in a number of ways (Table 1 ). In CD studies, investigators have often defined their own categories based on parameters such as severity, extent, location and/or type of adhesions [7, [10] [11] [12] . A recent publication has pro posed a standardized classification system for adhesions related to CD [13] .
Following a CD, the size of the uterus pre vents direct contact between the incision site and the intestines in the first few days. Therefore, most adhesions related to CDs are found in the lower abdomen between the uterus, bladder and Cesarean delivery (CD) is one of the most com mon obstetric surgeries. The number of CDs per formed has increased in the past decade, with a current rate of approximately 33% of all births in the USA [101] and 26% in Africa, Asia and Latin America [1] . Observational studies show an increase in complications as the number of subsequent CDs increases, including elevated risk for placenta accreta, hysterectomy, blood transfusion, intensive care unit admission and a significant increase in operation time and hospital stay [2, 3] . Postoperative adhesions are a common complication of major abdominal surgery, including CD. Adhesions form during healing and consist of fibrous scar tissue that often abnormally connects internal organs or structures. There is limited information in the literature on the management of adhesions relat ing to CD and no practice guidelines specific to the labor and delivery setting. The aim of this review is to summarize the clinical evidence on the occurrence and consequences of adhesions, and the efficacy of antiadhesion barriers in CD for an inter disciplinary labor and delivery health care team, and to consider the potential role of labor and delivery nurses in managing adhesions in this setting.
Adhesion formation
Adhesions form as a result of abnormal wound healing [4] [5] [6] [7] . During tissue healing, a fibrin clot is Adhesions following cesarean delivery: a review of their occurrence, consequences and preventative management using adhesion barriers Judith H Poole* The objective of this article is to provide a comprehensive review of the occurrence and consequences of postoperative adhesions following cesarean delivery (CD), and an overview of the published clinical data on prevention in this setting using adhesion barriers. Adhesions occur frequently after CD and the incidence increases with each subsequent CD. Repeat CDs are complicated by adhesions, which increase operating time, time to delivery and risk of bladder injury. Clinical data on the efficacy of adhesion prevention strategies specific to the setting of CD are limited. Two small, nonrandomized studies found that the use of absorbable anti-adhesion barriers was associated with a significant reduction in adhesion formation and a shorter time to delivery at repeat CD, compared with no barrier use. Implications for practice and research are discussed. There is a significant need for well-controlled, randomized clinical studies investigating adhesion prevention in the labor and delivery setting.
omentum [14] . The pathology behind the forma tion of adhesions following CD may differ from other surgeries owing to the substerile operative area, increased blood loss, the type of incision and the altered physiological and anatomical state of pregnancy [7, 14] . Amniotic fluid has fibrinolytic activity and may play a role in the prevention of adhesions [15] .
Consequences of adhesions
Abdominal adhesions are associated with sig nificant morbidity and can result in bowel [16] ; consequently the prevention of adhesions is a major unmet medical need. Adhesions also increase healthcare utilization and costs. A retrospective ana lysis of data from the 2005 Healthcare Cost and Utilization Pro ject's Nationwide Inpatient Sample found that adhesiolysisrelated procedures were associated with 967,332 days of inpatient care and costs of US$2.25 billion [17] . Of the secondary adhesi olysis procedures recorded in 2005, CDrelated adhesiolysis accounted for healthcare costs of US$18 million [17] .
Adhesion prevention
Modification of surgical technique is beneficial, but not sufficient alone to prevent adhesion formation [6] . A variety of adhesionprevention treatments have been investigated and are sum marized in Table 2 . Currently, the most widely used adhesionprevention agents in the labor and delivery setting that are approved by the US FDA are oxidized regenerated cellulose (ORC; Interceed ® ; Ethicon Inc., NJ, USA) and sodium hyaluronate/carboxymethylcellulose (HA/CMC; Seprafilm ® ; Genzyme Biosurgery, MA, USA). ORC and HA/CMC are absorbable barriers that act as a mechanical barrier between adjacent tissues to attempt to reduce adhesion formation while healing takes place.
Review of the literature: adhesions & CD
For this narrative review, English language publications reporting human studies that were published between July 2001 and May 2013 were retrieved from the MEDLINE/PubMed online database using relevant multiple search terms including adhesion(s), Csection, cesar ean, barrier(s), adhesionrelated disorder, Inter ceed, oxidized regenerated cellulose, Seprafilm, sodium hyaluronate carboxymethylcellulose, Adept ® (Baxter Healthcare, IL, USA) and icodex trin. Abstracts were reviewed to identify articles relating to adhesions in the setting of CD; 71 were selected for full review. Of these, 45 met the only inclusion criterion of original research reporting the frequency, consequences or preven tion of adhesions in CD, and all are included in this synthesis. Case studies, reviews and letters were excluded. As data on adhesion barriers in CD are extremely limited, the section on safety was supplemented with information regarding safety in other gynecological surgeries (obtained outside of the literature search described above).
Frequency of adhesions after CD
In published prospective and retrospective stud ies investigating adhesions after primary CD, the occurrence rate varied widely, with 24-73% of women affected [7, 8, 10, 12, 18, 19] . This variation in incidence may, in part, be due to differing surgi cal techniques and the adhesionscoring methods used. A number of different surgical techniques are used in CD that may affect the rate of adhe sion occurrence, in particular closure or nonclo sure of the peritoneum following delivery. The rate may also differ depending on the type of uterine incision used [20] and the technique used for hys terotomy closure [21] . This remains controversial as conflicting results have been seen in different studies. The majority of studies appear to support a lower adhesion rate following closure of the peri toneum, although the surgical techniques were not standardized and other contributing factors may be involved [7, 10, [22] [23] [24] [25] [26] [27] [28] . By contrast, other studies have supported a lower adhesion rate with nonclo sure [29] [30] [31] [32] [33] or have observed no difference in over all adhesion occurrence with closure versus non closure [9, 34, 35] . A secondary ana lysis of data from one study found reduced adhesion occurrence following closure of the rectus muscles, whereas closure of the visceral peritoneum appeared to increase adhesions [36] . Longterm followup from the CAESAR study -a factorial, randomized con trolled trial assessing different surgical techniques for CD -may assist in clarifying the effects of closure/nonclosure [37] , although it is not known when these data might be available.
Regardless of the surgical method used, it is clear that adhesions frequently occur after CD and that the incidence increases with each subsequent CD, as shown by many clinical studies [7, 8, 11, 12, 18, 19, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] .
Consequences of adhesions in CD
Clinical data describing the effects of adhesions specifically for repeat CDs are summarized in Table 3 . The presence of adhesions increases the difficulty in performing repeat CDs because they delay entry into the uterine cavity, which increases time to delivery and total operation time [8, 11, 12, 19, 48] . Delivery time is particularly impor tant if fetal distress is present, although two recent prospective cohort analyses found no statistically significant adverse affects on neonatal condition at birth with longer incisiontodelivery times [19, 48] . It should be noted that repeat CDs with no documented adhesions also require a longer delivery time, but not to the same extent as those with adhesions present [8] . The presence of adhe sions is also associated with a greater risk of blad der injury [49] [50] [51] .
Other complications may also occur as a result of postCD adhesions. A retrospective case review of CDs that were followed by exploratory relaparotomy found a bowel obstruction, caused by adhesions, in one out of 28 (3.6%) cases assessed [52] . Adhesions between the anterior lower uterine segment and the anterior abdominal wall may also result in technical limitations for pelvic ultrasound imaging [53] . Surprisingly, in a pro spective study of 50 women undergoing a second CD, there was no correlation between the pres ence of adhesions and abdominal pain, chronic constipation, dyspareunia or dysmenorrhea, and no correlation between the severity and quantity of adhesions and symptom severity, leading the authors to suggest that adhesions after CD may differ from those after other types of abdominal surgery [14] . However, the authors acknowledge that this was a small pilot study and that further research is needed. Other studies have indicated that the number of complications increases with an increasing number of repeat CDs, which may be associated with the higher incidence of adhe sions in these patients [19, 31, 41, 45, 46] . By contrast, a 
Method
Adhesion-prevention technique/agent Comments Ref.
Modification of surgical technique
Reduce trauma and tissue ischemia (e.g., less invasive techniques and gentle handling of tissue); minimize foreign materials (e.g., glove powder and abdominal swabs) and electrocauterization; nonreactive sutures; optimal hemostasis; minimize tissue drying with liberal irrigation Beneficial but not sufficient alone to prevent adhesion formation [6, 57, 67] Hydroflotation (anti-adhesion fluids and gels)
Instillation of large volumes of crystalloid isotonic solutions (e.g., saline or Ringer's lactate) into peritoneum after surgery Not effective in preventing adhesion formation (meta-ana lysis) [65] Steroids Insufficient evidence of efficacy in Cochrane review of randomized trials [66] Dextran Insufficient evidence of efficacy in Cochrane review of randomized trials [66] Icodextrin 4% (Adept ® ; Baxter Healthcare, IL, USA) Approved for intraperitoneal use as adjunct to good surgical technique for reduction of postsurgical adhesions in patients undergoing gynecological laparoscopic adhesiolysis; has been used in past, but not currently widely used in the USA for CD Approved for reconstruction of peritoneum where minimal adhesions are desired. Sutured/stapled into place and remains in the body or must be removed surgically a few days after application; therefore limited in usefulness. Not generally used in labor and delivery setting in the USA [67] CD: Cesarean delivery.
case-control study of 602 women found no sig nificant increase in surgery time in patients with two or more previous CDs compared with those having only one, even though the occurrence of adhesions was significantly higher in the group with two or more [43] .
Adhesion prevention in CD: adhesion barriers
Published clinical data on the efficacy of adhe sion barriers specifically in CD are very limited, with only two studies identified for this review. A retrospective cohort ana lysis study of 112 women evaluated the efficacy of ORC in reducing the incidence of adhesion formation and severity at primary CD compared with a control group (no barrier used) [28] . Placement of the adhesion bar rier was one strip over the closed hysterotomy and another perpendicular to the first, over the anterior uterine serosa, to form an inverted T shape. At repeat CD, the proportion of women with no adhesions was significantly higher in the barrier group versus the nobarrier group and there were no grade 3 adhesions in the barrier group (Figure 1a ). Parietal peritoneal closure was performed in 56% of women in the barrier group and 44% in the nobarrier group, which also influenced adhesion rates. The lowest adhesion rates were seen in women who had barrier place ment and closure (Figure 1b) , and there was a sta tistically significant longer mean time to delivery in the nobarrier group versus the barrier group ( Figure 1C) . The odds ratio of adhesion formation in the barrier group versus the nobarrier group was 0.54 (95% CI: 1.7 to 0.78; p = 0.03), con trolling for peritoneal closure. No significant dif ference was found in adhesion occurrence accord ing to type of suture used (chromic vs vicryl). A cohort study evaluated the efficacy of HA/CMC in preventing adhesions at repeat CD [54] . The proportion of patients with adhe sions was significantly lower in the barrier group versus the control group (Figure 2a) , and adhesion score was significantly lower (Figure 2b) . Delivery time and total operating time was significantly lower in the barrier group ( Figure 2C) . However, there was no significant difference in blood loss ( Figure 2D) .
Although these two studies provided positive data on the reduction in adhesion occurrence with the use of adhesion barriers in CDs, they are both small, nonrandomized studies; hence the level of evidence is low. Large, highquality, randomized studies are therefore needed to confirm these limited data on adhesion prevention in CD. Two ongoing clinical trials are assessing the effective ness of HA/CMC versus no barrier in reducing adhesion formation in CDs; one is a multicenter, randomized, controlled, singleblind study and the other a randomized, doubleblind trial. Data taken from [28] .
Data from studies of other types of gyne cological surgery have provided evidence for the efficacy of adhesion barriers; however, this cannot be extrapolated to the setting of CD, particularly as the formation of adhesions may differ follow ing CDs compared with other surgeries, based on the surgical environment. No studies assessing other adhesionprevention strategies in CD were identified in the literature search.
Safety of absorbable adhesion barriers
No adverse effects associated with the use of absorbable adhesion barriers were reported in the two clinical trials evaluating their efficacy in CD surgery. In addition, there were no adverse effects reported in studies of barriers in gyneco logical surgery [55, 56] . If there is a risk of ongoing bleeding from the surgical site, ORC should not be used as it may increase the risk of adhesions in this situation [57] . Concerns were previously raised as to whether HA/CMC could promote tumor growth because it contains hyaluronan, which is known to promote cell migration, differentiation and proliferation. However, in a retrospective case review of 202 women, HA/CMC did not increase the rate of early postoperative complications fol lowing surgery for gynecological cancer, and did not adversely affect diseasefree survival or over all survival in these patients [58] . One retrospec tive study of HA/CMC in patients undergoing laparotomy for ovarian, fallopian tube or primary peritoneal cancers suggested an increase in post operative intraabdominal fluid collections in the HA/CMC group versus the control group. How ever, this patient population represents a group undergoing extensive surgery for malignancy, with the majority undergoing debulking proce dures and most of the fluid collections occurring † For adhesion score, adhesions were rated by location (none = 0, intrauterine = 1, from uterine body to bowel or pelvic sidewall = 2); thickness (none = 0, filmy = 1, thick = 2); and extent (none = 0, covering <50% of injured surface = 1, covering >50% of injured surface = 2). Data taken from [54] .
in those having large bowel resections. The authors noted that the data therefore should not be extrapolated to other patient populations [59] .
Implications for practice & research
Prevention of adhesions following CD may reduce the risk of complications during future pelvic/ abdominal surgeries, including repeat CD, and could reduce the risk of secondary infertility, bowel obstruction, and, potentially, chronic pel vic pain. In the context of repeat CD, it may assist in keeping delivery times to a minimum, which is especially important if fetal distress is present, and minimize anesthesia time for both mother and baby. It could be speculated that a reduced need for manipulation without the complication of adhe sions may decrease the need for blood transfusion and potentially lower the risk of infection, allow ing many women to leave hospital sooner after a CD. Adhesion prevention is important in CDs because this procedure cannot be replaced with minimally invasive laparoscopic methods; open surgery remains essential [14] . The rate of CDs has been increasing throughout the past decade, so the number of women likely to be affected by adhe sions has increased and may continue to do so if the trend for an increase in CD rate is maintained. The rate of repeat CD is also increasing, accom panied by a decline in the rate of vaginal birth after cesarean. Although there are no published data on the consequences of adhesions in women having a vaginal birth after cesarean, the presence of adhesions may increase delivery time regardless of delivery method, which increases the potential for complications for mother and baby. A secondary benefit of adhesion reduction is reduced healthcare utilization, together with its related costs. A cost-effectiveness ana lysis indicated that an adhesionprevention strategy utilizing an adhesion barrier (HA/CMC) was more cost effective than routine care without an adhesionprevention measure in patients under going radical hysterectomy and pelvic lymph adenectomy for stage IB cervical cancer [60] . However, as discussed previously, the pathology behind the formation of adhesions following CD may differ from other surgeries; therefore, costbenefit analyses in the CD setting are needed to confirm the potential healthcare utilization and cost benefits. A medical database ana lysis found that healthcare costs, length of hospital stay, oper ating time and overall complication rates were significantly greater in women undergoing adhe siolysis at the time of repeat CD than in those not undergoing adhesiolysis in a matched control group [61] .
The role of the labor and delivery nurse in the prevention and management of adhesions cur rently centers on raising awareness within the interdisciplinary healthcare team regarding the high rate of adhesion occurrence after CD and the potential consequences. Repeat surgery for adhesiolysis is likely to be carried out by a general surgeon and therefore the gynecology/obstetric healthcare team may not be fully aware of the extent of complications due to adhesions in patients who have previously been in their care. There is a significant need for research and well controlled, randomized clinical studies investigat ing methods of adhesion prevention in the labor and delivery setting. Substantial gaps exist in the currently published data regarding the efficacy of barriers in reducing adhesions after CD, and the effects on clinical outcomes such as length of hospital stay, reduction in complication rate, and healthcare utilization and costs. As clinical trial data on the efficacy of adhesion barriers in CD are presently very limited, the expected benefits are mostly extrapolated from clinical studies of other gynecologic/pelvic surgery. Once stronger evidence is reported on their efficacy in the CD setting, the role of labor and delivery nurses could also extend to ensuring the availability of adhe sion barriers on the unit as, if barriers are available to use, surgeons are more likely to consider using them as part of the CD procedure. All labor and delivery units would benefit from having an adhe sion risk reduction/aversion strategy to prevent adhesions at primary CD rather than waiting until a dhesions are already present to tackle the problem.
Conclusion & future perspective
Adhesions are common after CD and their incidence increases with each subsequent proce dure. Abdominal adhesions are associated with significant morbidity including bowel obstruc tion, secondary infertility, chronic pelvic pain and a need for repeat surgery. However, data on the occurrence of these complications following CD are limited. Clinical studies show that adhe sions complicate subsequent CD surgery, with an increased operating time and time to delivery, which may increase the risk of adverse outcomes. Adhesions are also associated with an increased risk of bladder injury. Therefore, prevention of adhesion formation following CD is an unmet medical need. Data on adhesion prevention spe cific to CDs are scarce, but two small, nonran domized studies support a reduction in adhesion formation and time to delivery at repeat CD with absorbable adhesion barriers [28, 54] . The use of antiadhesion agents should be an adjunct to good surgical technique rather than a replacement. Labor and delivery nurses could aid the preven tion and management of adhesions by raising awareness within the healthcare team regarding the high rate of adhesion occurrence after CDs, and the potential consequences. Data from ongo ing randomized clinical trials of adhesion barriers will likely play a key role in determining whether their use in CD becomes widely accepted. Adhe sion prevention in the labor and delivery setting should be a key area for future research.
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Executive summary

Adhesion formation, consequences & prevention
• Cesarean delivery (CD) is one of the most common obstetric surgeries.
• Postoperative adhesions are a common complication of abdominal surgery and can cause bowel obstruction, chronic pelvic pain, secondary infertility and complications during subsequent surgery. • The only treatment is surgical lysis, but this often perpetuates adhesion formation.
• Good surgical technique is beneficial but not sufficient to prevent adhesions. Several adhesion-prevention strategies have been investigated; the most widely used in the labor and delivery setting are absorbable anti-adhesion barriers.
Adhesions after CD
• Adhesions frequently form after CD and their incidence increases with each subsequent CD.
Consequences of adhesions in CD
• Adhesions may complicate subsequent CDs by delaying entry into the uterine cavity, increasing time to delivery and total operation time. • Adhesions are also associated with a greater risk of bladder injury.
Efficacy of adhesion barriers in CD
• Clinical data on the efficacy of adhesion barriers in CD are very limited.
• Two cohort studies have shown that absorbable adhesion barriers significantly reduced adhesion formation following CD compared with a control group (no barrier used). • Time to delivery was also significantly reduced with barrier use versus no barrier.
Safety of adhesion barriers
• No adverse effects were reported in studies of adhesion barriers in CD and other gynecological surgeries.
Implications for practice & research
• Prevention of adhesions following CD may reduce the risk of secondary infertility, bowel obstruction and complications during future surgeries, and could help minimize delivery time for repeat CDs. • Potential reductions in healthcare utilization and costs are a secondary benefit of adhesion reduction.
• Labor and delivery nurses could aid adhesion prevention and management by raising awareness of adhesions and their consequences within the healthcare team.
Conclusion & future perspective
• Combined with good surgical technique, adhesion barriers may reduce adhesion formation following CD, thus preventing adhesion-related complications at repeat CD. • Adhesion prevention in the labor and delivery setting should be a key area for future research.
